Hemostasis Disorders
📧 Sign up to get email alerts when something new happens for Hemostasis Disorders.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2018-10-10EMA Withdrawn: Raplixa (human fibrinogen;human thrombin) — Mallinckrodt Pharmaceuticals Ireland Limited
Raplixa, a human fibrinogen and human thrombin product, has been withdrawn from the market by Mallinckrodt Pharmaceuticals Ireland Limited.
-
EMA withdrawal · 2018-04-03EMA Withdrawn: Evarrest (human fibrinogen;human thrombin) — Omrix Biopharmaceuticals N. V.
Evarrest (human fibrinogen; human thrombin) has been withdrawn from EMA authorization.